Fighting antibiotic resistance
Amferia
Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia's core focus is preventive healthcare and wound care where the goal is to provide highly efficient anti-infective medical devices that can prevent bacterial infections including those caused by antibiotic resistant bacteria.
Amferia
CEO:Anand Kumar Rajasekharan
First investment year:2020
Business sector:Life Science, Medtech
Visit website